SCHEMBL7148818

SCHEMBL7148818

COc1ccc(-c2cccs2)n2nc(NC(=O)c3cccc(CCl)c3)nc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.42
ALDH1A1 P00352 6/20 0.42
HPGD P15428 5/20 0.42
NPSR1 Q6W5P4 5/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 5/20 0.40
LMNA P02545 3/20 0.40
HTT P42858 2/20 0.40
HSD17B10 Q99714 2/20 0.40
USP2 O75604 1/20 0.40
F2 P00734 1/20 0.40
TP53 P04637 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7043536 0.89 MAPT (0.48) KDM4EALDH1A1HPGDNPSR1SMN1; SMN2
SCHEMBL7147869 0.88 NPC1 (0.56) KDM4EALDH1A1HPGDNPSR1SMN1; SMN2
SCHEMBL7042535 0.87 CYP1A2 (0.44) KDM4EALDH1A1HPGDNPSR1SMN1; SMN2
SCHEMBL7041864 0.85 HDAC6 (0.44) KDM4EALDH1A1HPGDNPSR1SMN1; SMN2
SCHEMBL7041685 0.84 GABRD (0.47) KDM4EALDH1A1HPGDNPSR1SMN1; SMN2
SCHEMBL7146666 0.83 ALDH1A1 (0.53) KDM4EALDH1A1HPGDNPSR1SMN1; SMN2
SCHEMBL7042500 0.83 MAPT (0.46) KDM4EALDH1A1HPGDNPSR1SMN1; SMN2
SCHEMBL7151229 0.80 KMT2A (0.51) KDM4EALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL7145678 0.78 MAPT (0.44) KDM4EALDH1A1HPGDNPSR1SMN1; SMN2
SCHEMBL7143995 0.74 ADORA1 (0.53) KDM4EALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed